Status:
COMPLETED
Three Inflation Methods of Ambú Auragain™ and Its Adverse Effects
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz
Conditions:
Laryngeal Mask Airway
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Laryngeal mask is a common supraglottic device (SGD) used in the daily practice for airway management. Consecutive generations have permitted an expansion of its use. At the moment, the SGD is being u...
Detailed Description
This is a prospective randomized controlled trial. The study was approved by the Ethics Committee of University Hospital of La Paz, Madrid. Written informed consent will be obtained from each particip...
Eligibility Criteria
Inclusion
- Patients age between 18 and 90 years
- American Society of Anesthesiologist (ASA) physical status I-III
- fiberoptic bronchoscopy procedure and EBUS-TBNA procedure programmed.
- Fasted for 6 hours before procedure.
- Management of the airway for the same anesthetic.
- Use de laryngeal mask airway for boarding and maintenance of airway permeability.
Exclusion
- LMA is contraindicated because high risk of aspiration (full stomach, gastroesophageal reflux history, pregnant)
- predictors of difficult airway such restricted mouth opening (\< 2 cm of interincisal distance)
- patients with any pathology of the neck, upper respiratory or upper alimentary tract
- dysphagia o hoarseness.
Key Trial Info
Start Date :
January 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2021
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04795544
Start Date
January 18 2021
End Date
October 30 2021
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teresa Prim Martinez
Madrid, Spain, 28034